Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trehalose for aortic inflammation in cancer patients
IRCT20130829014521N20Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2022
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, single-arm trial of trehalose in Aortitis and cancer, sponsored by Mashhad University of Medical Sciences. Primary endpoint: Improvement in aortic vascular inflammation by PET scan. Started Jun 2022; status: completed.
02
Drugs
trehalose
03
Conditions
Aortitiscancer
Beyond the preview
Go deeper on IRCT20130829014521N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130829014521N20.